Live feed08:30:00·8mPRReleasevia QuantisnowAlpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's DiseaseByQuantisnow·Wall Street's wire, on your screen.ACOG· Alpha Cognition Inc.
